Pituitary hormone deficiency

Gene: GHRHR

Green List (high evidence)

GHRHR (growth hormone releasing hormone receptor)
EnsemblGeneIds (GRCh38): ENSG00000106128
EnsemblGeneIds (GRCh37): ENSG00000106128
OMIM: 139191, ClinGen, DECIPHER
GHRHR is in 5 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

IGHD type IV is characterized by early and severe growth failure (height SDS up to -7.4), a blunted growth hormone (GH) response to different provocation tests and low insulin-like growth factor-I and IGF-binding protein-3 concentrations, and a good response to growth hormone treatment. At least three unrelated families reported.
Created: 24 Aug 2021, 11:48 a.m. | Last Modified: 24 Aug 2021, 11:48 a.m.
Panel Version: 0.8924

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Growth hormone deficiency, isolated, type IV, MIM# 618157

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Genomics England PanelApp
  • Victorian Clinical Genetics Services
Phenotypes
  • Growth hormone deficiency, isolated, type IV (618157)
OMIM
139191
ClinGen
GHRHR
DECIPHER
GHRHR
Clinvar variants
Variants in GHRHR
Penetrance
None
Publications
Panels with this gene

History Filter Activity

11 Dec 2025, Gel status: 3

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: ghrhr has been classified as Green List (High Evidence).

11 Dec 2025, Gel status: 3

Set publications

Chirag Patel (Genetic Health Queensland)

Publications for gene: GHRHR were set to

13 Jul 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Seb Lunke (Victorian Clinical Genetics Services)

gene: GHRHR was added gene: GHRHR was added to Pituitary hormone deficiency. Sources: Genomics England PanelApp,Expert Review Green Mode of inheritance for gene: GHRHR was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: GHRHR were set to Growth hormone deficiency, isolated, type IV (618157)